PAVmed (NASDAQ: PAVMU) is a multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The company’s goal is to enhance and accelerate value creation by employing a business model focused on capital efficiency and speed to market. PAVmed is building a deep development product pipeline with attractive regulatory pathways and market opportunities encompassing a broad spectrum of clinical areas including carpal tunnel syndrome, medical infusions, interventional radiology, tissue ablation, and cardiovascular intervention. For more information, visit the company’s website at www.pavm.com